DEALS
Zhong Lun Advises Chenguang Biotech Group Co., Ltd. on IPO and ChiNext Listing
Zhong Lun Advises Chenguang Biotech Group Co., Ltd. on IPO and ChiNext Listing
Release time：2010-09-10
Voice Announcements
On September 7, 2010, the China Securities Regulatory Commission approved the initial public offering (IPO) and listing of Chenguang Biotech Group Co., Ltd. on the ChiNext market of the Shenzhen Stock Exchange.
Zhong Lun Law Firm provided full legal services for Chenguang Biotech in the IPO and listing. The service team was led by partner Guo Kejun and also composed of associates Yang Sujuan and Yao Qiming. The underwriter was PingAn Securities Co., Ltd.
Chenguang Biotech, which principally engages in the production, research and sale of capsanthin, lutein and other natural plant extracts, plans to issue 23 million new shares, accounting for 25.62% of its enlarged share capital.
Professionals
-
-
Qiming YAO
Equity Partner
BeijingPractices： Chinese Mainland Capital Markets,Hong Kong & Overseas Capital Markets,Private Equity & Investment FundsIndustries： Telecommunications & Internet,Information & Intelligence Technology,Education & Training,Media-Sports & Entertainment -
Qiming YAO
Equity Partner
Beijing
-